Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

Remote Assist allows remote programming, processor setting adjustments and counselling via a live video session Upcoming availability for Cochlear Nucleus 7, Kanso 2 and Baha 6 Max Sound Processors Part of Cochlear's investment in Connected Care technology, enabling consistent, personalized care across care settings to optimize patient outcomes

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance in the last month for its Cochlearâ„¢ Remote Assist solution in the Nucleus® and Baha® Systems. The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear’s existing Remote Care offerings.

Quality care, anywhere
Remote Assist delivers the ability for clinicians to engage with their patients through a live video, audio or chat session in the fitting software and connect to the sound processor via the patient’s Nucleus or Baha Smart App.* Once connected to the patient, the hearing health provider can make programming adjustments, enable processor settings and provide counseling via a live video session. Any changes are saved remotely to the patient’s sound processor.

Cochlear’s Remote Care solutions offer hearing implant patients the convenience of quality hearing care without the need to visit a clinic. With new flexibility to manage patient progress remotely, hearing health providers have time to offer care to more patients, including those who may be limited by location, health, mobility or work commitments.

For cochlear implant patients with Nucleus 7 and Kanso® 2 Sound Processors, Remote Care consists of two options:

  • Remote Check, FDA approved in April 2020, which allows patients to complete a convenient, at-home hearing review without visiting the clinic.** Results are then sent remotely to their clinician for review. Clinicians can analyze information gathered during the Remote Check to determine if and how further follow up is needed at that time.
  • Remote Assist, which is available to clinicians in Custom Sound® Pro and connects to the patient’s sound processor via the Nucleus Smart App to make live global changes to the patient’s programs via Master Volume, Bass & Treble (MVBT) adjustments and enable other processor features.

For bone conduction patients with Baha 6 Max Sound Processors, Remote Assist is available to clinicians in Baha Fitting Software 6 with connection to the sound processor via the Baha Smart App. Remote Assist for Baha 6 Max allows clinicians to fully program and adjust the sound processor for the patient, including performing BC Direct (in situ audiometry) and Feedback Analyzer functions.

“Through Cochlear’s Remote Check and Remote Assist, our innovative and secure Remote Care solutions further enhance clinical practice by bringing more options for monitoring patient performance and optimizing hearing outcomes remotely – ultimately providing care when and where it’s needed,” said Tony Manna, President, Cochlear Americas. “Our Remote Care solutions have been carefully designed and tested to meet rigorous quality and security standards, giving our hearing implant recipients and their hearing care professionals the confidence to receive and deliver quality care outside of a medical office.”

Inspired by connecting people with care
The Remote Care offerings are part of Cochlear’s Connected Care portfolio, transforming how people connect with hearing care across different care settings – from the surgical suite to the clinic, and into a patient’s everyday life. Connected Care offers new tools that give hearing care professionals the flexibility to customize patient care, increase clinic efficiency and maximize their time delivering quality patient care. For patients, Connected Care provides convenient ways to access quality hearing care when and where they need it throughout their hearing journey.

“We understand that the expectations and preferences of those using a Cochlear hearing implant change over time. That’s why we use our innovative technology to develop new digital tools that support an evolving care model to meet changing needs,” said Mia Visconti, Director, Connected Care Innovation Product & Services, Cochlear Americas. “With Cochlear’s Remote Care solutions, we can securely provide quality hearing care without requiring a recipient to visit a clinic by leveraging the advanced connectivity features of our Nucleus and Baha Sound Processors and our leading app technology.”

Cochlear will immediately begin a controlled market release of Remote Assist in the U.S. by partnering with hearing healthcare providers and hospitals to provide professionals with more options for monitoring patient performance and optimizing hearing outcomes – providing patient care when and where it’s needed.

Cochlear anticipates Remote Assist approval in Canada to be obtained in late 2021 for the Nucleus System and early 2022 for the Baha System.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Led by researchers at NYU Grossman School of Medicine, the study results add to evidence that neighboring brain regions, the inferior frontal gyrus and the motor cortex, play an important role in such planning before words are said aloud. Both are part of the folded top layers of the brain, or cerebral cortex, which has long been known to control the muscle (motor) movements in the throat and mouth needed to produce speech. Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.
PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy